Raj, Nitya

Publications

Sort by

Co-Author Network

DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression. Journal of vascular and interventional radiology : JVIR. 2018 Academic Article GET IT
Times cited: 12
Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2018 Information Resource GET IT
Times cited: 3
Commentary: Somatostatin analogs-How we choose, and why. Seminars in oncology. 2017 Academic Article GET IT
Times cited: 1
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. Pancreas. 2017 Academic Article GET IT
Times cited: 27
Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug. The oncologist. 2017 Academic Article GET IT
Times cited: 38
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine. 2017 Academic Article GET IT
Times cited: 2359
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated. Pancreas. 2017 Academic Article GET IT
Times cited: 101
Current clinical trials of targeted agents for well-differentiated neuroendocrine tumors. Pancreas. 2014 Review GET IT
Times cited: 3